Completed projects

• Development and initial content validation of a new version of the damage index in thrombotic antiphospholipid syndrome (DIAPSv2).
• The progress of this project was presented at the following congresses:
• Pan-American Congress of Rheumatology 2023 (PANLAR 2023)
• Pan-American Congress of Rheumatology 2024 (PANLAR 2024)
• National Congress of the Mexican College of Rheumatology 2024
• European Congress of Rheumatology (EULAR 2024)
   

Ongoing projects

 

• Chronic damage and quality of life in patients with Antiphospholipid Antibody Syndrome.
   

Planned projects

 

• Chronic damage and quality of life in patients with Antiphospholipid Antibody Syndrome in a multicenter Latin American cohort.
• Clinical and epidemiological characterization of Antiphospholipid Antibody Syndrome patients in Latin America, according to the newly proposed classification criteria.
   

Academic activities

 

• Mexican Congress of Rheumatology (2024): Plenary Session Amigo M, Goycochea-Robles M, Medina-García G, Martínez L, Mendoza C, et al. First phase report of the update and validation of the cumulative damage index in thrombotic antiphospholipid syndrome (DIAPSv2).
  Reumatol. Clin. 2024 (Supplement); 20 Ext 1:9.
• LII Mexican Congress of Rheumatology (2024): Symposium Chronic damage in APS: Why measure the irreversible? Amigo M, Goycochea-Robles M, Medina-García G, Martínez L, Mendoza C, et al.
  Reumatol Clin 2024 (Supplement); 20:1-17.
• Pan-American Congress of Rheumatology 2024 (PANLAR 2024) Tools to measure activity, damage, and classify Antiphospholipid Syndrome.
• European Congress of Rheumatology (EULAR 2024): Poster Presentation New version of Damage Index in Thrombosis Antiphospholipid Syndrome: DIAPSv2.